CVC BRASIL (CVCB3) Main Indicators
Basic Data - CVCB3
| Company | CVC BRASIL |
| Corporate Name | CVC BRASIL OPERADORA E AGÊNCIA DE VIAGENS S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Serviços de turismo. compreendendo a intermediação. individualmente ou na forma agregada. de passagens aéreas. transporte terrestre. reservas de hotéis. passagens de cruzeiros marítimos. entre outros. |
| Share | CVCB3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 2.07 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 81.41 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Consumo Cíclico |
| Subsector | Viagens e Lazer |
| Segment | Viagens e Turismo |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 09/19/2024 | |
Relative Prices - CVCB3
| Price/Earnings | -4.98 |
| Price/SBV | 1.93 |
| Price/Net Sales | 0.71 |
| Price/CFO | -3.50 |
| Price/FCF | -3.42 |
| Price/Total Assets | 0.28 |
| Price/EBIT | -197.13 |
| Price/Working Capital | -6.59 |
| Price/NCAV | -0.31 |
| EV/EBIT | -280.69 |
| EV/EBITDA | 7.18 |
| EV/Net Sales | 1.01 |
| EV/CFO | -4.98 |
| EV/FCF | -4.87 |
| EV/Total Assets | 0.40 |
| Company Market Cap | R$ 1.09 B |
| Enterprise Value | R$ 1.55 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 2.07 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 0.00% |
| Updated 09/19/2024 | |
Income Statement - CVCB3
| Net Revenue | R$ 1.54 B |
| Gross Result | R$ 1.34 B |
| EBIT | - R$ 5.52 M |
| Depreciation and Amortization | - R$ 221.16 M |
| EBITDA | R$ 215.64 M |
| Net Profit | - R$ 218.52 M |
| Net Profit/Share | - R$ 0.42 |
| Updated 08/07/2024 | |
| Net Revenue | R$ 316.50 M |
| Gross Result | R$ 294.02 M |
| EBIT | R$ 180.00 thousand |
| Depreciation and Amortization | - R$ 58.55 M |
| EBITDA | R$ 58.73 M |
| Net Profit | - R$ 22.17 M |
| Profit/Share | - R$ 0.04 |
| Updated 08/07/2024 | |
Price and Volume Behavior - CVCB3
| Lowest Price 52 weeks | R$ 1.71 |
| Highest Price 52 weeks | R$ 4.01 |
| Variation 2024 | -36.89% |
| Variation 1 year | -8.81% |
| Variation 2 years(total) | -71.29% |
| Variation 2 years(yearly) | -46.28% |
| Variation 3 years(total) | -89.86% |
| Variation 3 years(yearly) | -53.31% |
| Variation 4 years(total) | -88.02% |
| Variation 4 years(yearly) | -41.15% |
| Variation 5 years(total) | -96.05% |
| Variation 5 years(yearly) | -47.55% |
| Average Daily Volume (3 months) | R$ 36.21 M |
| Updated 09/19/2024 | |
Returns and Margins - CVCB3
| Return on Initial Tangible Capital | 2.35% |
| Return on Initial Invested Capital | -0.54% |
| Pre-Tax Return on Initial Tangible Capital | 3.56% |
| Pre-Tax Return on Initial Invested Capital | -0.82% |
| Return on Initial Shareholder´s Equity | -41.23% |
| Return on Initial Asset | -5.30% |
| Gross Margin | 87.11% |
| Net Margin | -14.21% |
| EBIT Margin | -0.36% |
| EBITDA Margin | 14.02% |
| Initial Asset Turnover | 0.37 |
| Financial Leverage | 6.91 |
| Liabilities/Net Worth | 5.91 |
| Net Debt/EBITDA | 2.14 |
| Updated 08/07/2024 | |
Balance Sheet - CVCB3
| Cash and Cash Equivalents | R$ 244.16 M |
| Total Assets | R$ 3.90 B |
| Short-Term Debt | R$ 74.94 M |
| Long-Term Debt | R$ 630.39 M |
| Gross Debt | R$ 705.33 M |
| Net Debt | R$ 461.18 M |
| Shareholder´s Equity | R$ 564.12 M |
| Share Book Value | R$ 1.07 |
| Common Shares | 525,591,097 |
| Preferred Shares | 0 |
| Total | 525,591,097 |
| Common Shares in Treasury | 8,326 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 8,326 |
| Common Shares (Except Treasury) | 525,582,771 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 525,582,771 |
| Updated 08/07/2024 | |
Cash Flow - CVCB3
| Operating Cash Flow | - R$ 310.80 M |
| Cash Flow from Investments | - R$ 78.08 M |
| Financing Cash Flow | - R$ 23.38 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 401.99 M |
| Updated 08/07/2024 | |
| Operating Cash Flow | R$ 8.10 M |
| Cash Flow from Investments | - R$ 41.22 M |
| Financing Cash Flow | - R$ 171.80 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 196.00 M |
| Updated 08/07/2024 | |
Experimental - CVCB3
| CAPEX 3 months | - R$ 2.08 M |
| Free Cash Flow 3 months | R$ 6.03 M |
| CAPEX 12 months | - R$ 7.17 M |
| Free Cash Flow 12 months | - R$ 317.97 M |
| Updated 08/07/2024 | |